1-10 of 10
Alain Kentos
Close
Sort by
Journal Articles

Dynamic Frailty Status Enables Better Prediction of Survival Probability - Results of the HOVON 143 Study

Febe Smits, Kaz Groen, Mark-David Levin, Claudia Stege, Roel JW Van Kampen, Ellen Van Der Spek, Yavuz M Bilgin, Noortje Thielen, Inger S. Nijhof, Inge Ludwig, Esther G.M. De Waal, Yorick Sandberg, Alain Kentos, Gert Jan Timmers, Josien C Regelink, Matthijs Westerman, Koen de Heer, Marie Christiane Vekemans, Nazik Durdu-Rayman, Nicole de Graauw, Maarten R. Seefat, Niels WCJ van de Donk, Paula F Ypma, Kazem Nasserinejad, Sonja Zweegman
Journal: Blood
Blood (2023) 142 (Supplement 1): 342.
https://doi.org/10.1182/blood-2023-180006
Published: 2023
Journal Articles

Efficacy and Tolerability of Ixazomib, Daratumumab and Low Dose Dexamethasone (Ixa Dara dex) in Unfit and Frail Newly Diagnosed Multiple Myeloma (NDMM) Patients; Results of the Interim Efficacy Analysis of the Phase II HOVON 143 Study

Claudia A.M. Stege, MD, Kazem Nasserinejad, Ellen van der Spek, MD PhD, Roel J.W. Van Kampen, MD PhD, Maaike Sohne, MD, Noortje Thielen, MD PhD, Yavuz Bilgin, MD PhD, Esther G.M. De Waal, MD, Inge Ludwig, MD MSc, Maria B.L. Leijs, MD, Alain Kentos, MD, Gert Jan Timmers, MD PhD, Koen de Heer, MD, Matthijs Westerman, MD, Marie Christiane Vekemans, Nazik Durdu-Rayman, MD, Nicole C.H.P. van der Burg-de Graauw, MD, Niels W. C. J. Van De Donk, MD PhD, Pieter Sonneveld, Saskia K. Klein, MD PhD, Mark-David Levin, MD PhD, Sonja Zweegman, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 695.
https://doi.org/10.1182/blood-2019-121694
Published: 2019
Journal Articles

Efficacy and Safety of Ponatinib in CML and Ph+ ALL Patients in Real-World Clinical Practice: Data from a Belgian Registry

Timothy Devos, Koen Theunissen, Fleur Samantha Benghiat, Alain Gadisseur, Stef Meers, Dominik Selleslag, Gaëtan Vanstraelen, Pierre Zachée, Marc André, Philippe Lewalle, MD, Mia Janssen, Rik Schots, Koen Van Eygen, Alain Kentos, Marie Lejeune, Agnes Triffet, Inge Vrelust, Carolina Kuipers, Violaine Havelange
Journal: Blood
Blood (2018) 132 (Supplement 1): 1744.
https://doi.org/10.1182/blood-2018-99-114070
Published: 2018
Journal Articles

Safety in Patients with Multiple Myeloma Treated with Pomalidomide in a Real-World Setting According to Last Prior Treatment: A European Post-Authorization Safety Study

Niels Abildgaard, MD PhD, Marie-Christiane Vekemans, Barbara Gamberi, MD, Francesco Di Raimondo, MD, Angel Ramirez Payer, Charalampia Kyriakou, Alain Kentos, Elisabeth Kueenburg, Antonia Di Micco, Barbara Rosettani, Pamela Bacon, Margaret Atiba-Davies, Torben Plesner, MD DSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 3286.
https://doi.org/10.1182/blood-2018-99-111906
Published: 2018
Journal Articles

The role of rituximab in adults with warm antibody autoimmune hemolytic anemia

Daan Dierickx, Alain Kentos, André Delannoy
Journal: Blood
Blood (2015) 125 (21): 3223–3229.
https://doi.org/10.1182/blood-2015-01-588392
Published: 2015
Journal Articles

Superior outcomes associated with complete response in newly diagnosed multiple myeloma patients treated with nonintensive therapy: analysis of the phase 3 VISTA study of bortezomib plus melphalan-prednisone versus melphalan-prednisone

Clinical Trials & Observations
Jean-Luc Harousseau, Antonio Palumbo, Paul G. Richardson, Rudolf Schlag, Meletios A. Dimopoulos, Ofer Shpilberg, Martin Kropff, Alain Kentos, Michele Cavo, Anatoly Golenkov, Mieczyslaw Komarnicki, Maria-Victoria Mateos, Dixie-Lee Esseltine, Andrew Cakana, Kevin Liu, William Deraedt, Helgi van de Velde, Jesús F. San Miguel
Journal: Blood
Blood (2010) 116 (19): 3743–3750.
https://doi.org/10.1182/blood-2010-03-275800
Published: 2010
Includes: Supplemental data
Journal Articles

Rituximab Therapy for Autoimmune Hemolytic Anemia and Immune Thrombocytopenia: A Belgian Registry.

Daan Dierickx, MD, Philippe Mineur, MD, Agnes Triffet, MD, Alain Kentos, MD, Carine Keppens, MD, Pascal Pierre, MD, Alina Ferster, MD, Dominique Boulet, MD, Christiane Vermylen, MD, Bernard Deprijk, MD, Yves Beghin, MD, Marie-France Dresse, MD, Khalil Kargar, MD, Greet Bries, MD, Gregor Verhoef, MD, Andre Delannoy, MD
Journal: Blood
Blood (2007) 110 (11): 1737.
https://doi.org/10.1182/blood.V110.11.1737.1737
Published: 2007
Journal Articles

Valproic Acid Induces Apoptosis in Chronic Lymphocytic Leukemia Cells by Targeting Several Pro- and Anti-Apoptotic Genes.

Basile Stamatopoulos, PhD, Nathalie Meuleman, Alain Kentos, Philippe Hermans, Philippe Martiat, Dominique Bron, Laurence Lagneaux
Journal: Blood
Blood (2007) 110 (11): 3131.
https://doi.org/10.1182/blood.V110.11.3131.3131
Published: 2007
Journal Articles

Valproic Acid Induces Apoptosis in Chronic Lymphocytic Leukemia Cells through Activation of the Death Receptor Pathway and Potentiates TRAIL Response.

Laurence Lagneaux, PhD, Nicolas Gillet, Alain Delforge, PhD, Marielle Dejeneffe, Basile Stamatopoulos, Martine Massy, Nathalie Meuleman, MD, Alain Kentos, MD, Luc Willems, PhD, Dominique Bron, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 4949.
https://doi.org/10.1182/blood.V108.11.4949.4949
Published: 2006
Journal Articles

Circulating thrombopoietin as an in vivo growth factor for blast cells in acute myeloid leukemia

Francis Corazza, Christophe Hermans, Stéphanie D'Hondt, Alina Ferster, Alain Kentos, Yves Benoît, Eric Sariban
Journal: Blood
Blood (2006) 107 (6): 2525–2530.
https://doi.org/10.1182/blood-2005-06-2552
Published: 2006